Trends in Population-Based Studies of Human Genetics in Infectious Diseases

Abstract

Pathogen genetics is already a mainstay of public health investigation and control efforts; now advances in technology make it possible to investigate the role of human genetic variation in the epidemiology of infectious diseases. To describe trends in this field, we analyzed articles that were published from 2001 through 2010 and indexed by the HuGE Navigator, a curated online database of PubMed abstracts in human genome epidemiology. We extracted the principal findings from all meta-analyses and genome-wide association studies (GWAS) with an infectious disease-related outcome. Finally, we compared the representation of diseases in HuGE Navigator with their contributions to morbidity worldwide. We identified 3,730 articles on infectious diseases, including 27 meta-analyses and 23 GWAS. The number published each year increased from 148 in 2001 to 543 in 2010 but remained a small fraction (about 7%) of all studies in human genome epidemiology. Most articles were by authors from developed countries, but the percentage by authors from resource-limited countries increased from 9% to 25% during the period studied. The most commonly studied diseases were HIV/AIDS, tuberculosis, hepatitis B infection, hepatitis C infection, sepsis, and malaria. As genomic research methods become more affordable and accessible, population-based research on infectious diseases will be able to examine the role of variation in human as well as pathogen genomes. This approach offers new opportunities for understanding infectious disease susceptibility, severity, treatment, control, and prevention.

Keeping Pace with the Red Queen: Identifying the Genetic Basis of Susceptibility to Infectious Disease

“…Identifying such resistance genes would pave the way for genetic engineering of resistant crops and livestock, focus drug development efforts on likely targets, and open the door to gene therapeutic approaches within human populations. As the genomic revolution has progressed, it has become increasingly common to search for these “resistance genes” using genome-wide association studies (GWAS) ( Newport and Finan 2011 ; Rowell et al 2012 ). Loosely speaking, these studies compare the marker genotypes of individuals infected with disease and those uninfected and ask which loci predict an individual’s infection status.…”

The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis

“…Adoption, twin and heritability studies provided the first line of evidence that corroborate this 4 5 , leading to an increased interest in understanding of genetic background of infectious disease in the last decade of the 20 th century 6 7 . As a result, over 4,000 candidate-gene studies were published between 2001 and 2010, often focusing on respiratory infections and especially on tuberculosis 8 . However, these studies often provided conflicting results 9 10 .…”

Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa

“…9, 10 The ability to perform genome-wide association studies and large-scale genetic-variation surveys have led to an exponential increase in the amount of publicly available genetic data, 11 and an accompanying explosion in genomic comparisons both within and among populations. 12, 13, 14 These data support the clinical significance of identifying genetic outcomes of natural selection such as pinpointing susceptibility loci for infectious diseases plaguing human populations 15 or identifying responses to xenobiotic challenges. 16 These advances have opened the field of genomic medicine, which takes an individual's genetic data into account when planning clinical care 17, 18 and is indispensable in the push for personalized, or precision, medicine.…”